NEW YORK (GenomeWeb) – Israel-based plant genetics firm Evogene today reported that its second quarter revenues declined 9 percent year over year, due to a sharp drop in revenues related to share purchases.
NEW YORK (GenomeWeb) – Evogene today said that its collaboration with Bayer CropScience for wheat improvement has been amended to focus on novel genomic promoters from a prior focus on the discovery of additional genes and SNPs.
NEW YORK (GenomeWeb) – Evogene and Marrone Bio Innovations today announced a collaboration to discover new modes of biological action for insect control and to develop and commercialize new insect control products.
NEW YORK (GenomeWeb News) – Plant genomics firm Evogene has gone public in the US through the offering of 5 million shares of common stock at an offering price of $14.75 per share, bringing in gross proceeds of $73.75 million.
NEW YORK (GenomeWeb News) – Israeli plant genomics company Evogene said in an amended registration statement filed with the US Securities and Exchange Commission on Wednesday that it aims to raise $79 million in net proceeds through its initial public offering in the US.
NEW YORK (GenomeWeb News) – Evogene and Monsanto today announced they have expanded and extended an R&D collaboration aimed at identify plant genes related to yield, environmental stress, and fertilizer utilization.
NEW YORK (GenomeWeb News) – Evogene today announced that it and DuPont Pioneer have extended and expanded their multiyear research collaboration aimed at developing varieties of soybean resistant to Asian Soybean Rust, or ASR.